Higher executive control and visual memory performance predict treatment completion in borderline personality disorder

Psychotherapy and Psychosomatics

Volumn 81, Issue 1, 2011, Pages 38-43

  Fertuck, Eric A ^a,b,d   Keilp, John ^b   Song, Inkyung ^c   Morris, Melissa C ^b   Wilson, Scott T ^b   Brodsky, Beth S ^b   Stanley, Barbara ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d CITY COLLEGE OF NEW YORK   (United States)

Author keywords

Borderline personality disorder; Executive control; Executive function; Memory; Neuropsychology; Psychotherapy; Treatment adherence; Treatment completion; Treatment retention

Indexed keywords

ADULT; ARTICLE; AUTOMUTILATION; BORDERLINE STATE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EXECUTIVE FUNCTION; FEMALE; HAMILTON SCALE; HIGH RISK POPULATION; HUMAN; INTELLIGENCE QUOTIENT; MALE; NEUROPSYCHOLOGICAL TEST; OUTPATIENT CARE; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TASK PERFORMANCE; VISUAL MEMORY; WISCONSIN CARD SORTING TEST; WORKING MEMORY;

ADULT; AMBULATORY CARE; ATTENTION; BEHAVIOR THERAPY; BORDERLINE PERSONALITY DISORDER; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; FLUOXETINE; HUMANS; IMPULSIVE BEHAVIOR; LINEAR MODELS; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PATIENT COMPLIANCE; PLACEBOS; PSYCHOTHERAPY; SELF-INJURIOUS BEHAVIOR; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VISUAL PERCEPTION;

EID: 81555235323     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000329700     Document Type: Article

References (41)

1. Horesh N, Sever J, Apter A: A comparison of life events between suicidal adolescents with major depression and borderline personality disorder. Compr Psychiatry 2003; 44: 277-283. (Pubitemid 36875461)
2. Lenzenweger MF, Lane MC, Loranger AW, Kessler RC: DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 62: 553-564. (Pubitemid 47314365)
3. Chiesa M, Sharp R, Fonagy P: Clinical associations of deliberate self-injury and its impact on the outcome of community-based and long-term inpatient treatment for personality disorder. Psychother Psychosom 2011; 80: 100-109.
4. Binks CA, Fenton M, McCarthy L, Lee T, Adams CE, Duggan C: Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 2006;1: CD005652.
5. Oldham JM: Guideline Watch: Practice Guideline for the Treatment of Patients with Borderline Personality Disorder. Arlington, American Psychiatric Association, 2005.
6. Sneed JR, Fertuck EA, Kanellopoeulos D, Culang ME: Borderline personality disorder; in Sturmey P, Hersen M (eds): Handbook of Evidence-Based Practice in Clinical Psychology. Hoboken, Wiley, in press.
7. Gabbard GO: Do all roads lead to Rome? New findings on borderline personality disorder. Am J Psychiatry 2007; 164: 853-855. (Pubitemid 46972897)
8. Feurino L III, Silk KR: State of the art in the pharmacologic treatment of borderline personality disorder. Curr Psychiatry Rep 2011; 13: 69-75.
9. McMurran M, Huband N, Overton E: Noncompletion of personality disorder treatments: a systematic review of correlates, consequences, and interventions. Clin Psychol Rev 2010; 30: 277-287.
10. Linehan MM: Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, Guilford Press, 1993.
11. Allen DM: Techniques for reducing therapyinterfering behavior in patients with borderline personality disorder. Similarities in four diverse treatment paradigms. J Psychother Pract Res 1997; 6: 25-35. (Pubitemid 26401597)
12. Clarkin JF, Yeomans FE, Kernberg OF: Psychotherapy for Borderline Personality: Focusing on Object Relations, ed 1. Washington, American Psychiatric Press, 2006.
13. Nigg JT, Silk KR, Stavro G, Miller T: Disinhibition and borderline personality disorder. Dev Psychopathol 2005; 17: 1129-1149. (Pubitemid 43362207)
14. Fertuck EA, Lenzenweger MF, Clarkin JF, Hoermann S, Stanley B: Executive neurocognition, memory systems, and borderline personality disorder. Clin Psychol Rev 2006; 26: 346-375.
15. Ruocco AC: The neuropsychology of borderline personality disorder: a meta-analysis and review. Psychiatry Res 2005; 137: 191-202. (Pubitemid 41712776)
16. Posner MI, Rothbart MK, Vizueta N, Levy KN, Evans DE, Clarkin JF: Attentional mechanisms of borderline personality disorder. Proc Natl Acad Sci USA 2002; 99: 16366-16370. (Pubitemid 35469146)
17. Fertuck EA, Marsano-Jozefowicz S, Stanley B, Tryon WW, Oquendo M, Mann JJ, Keilp JG: The impact of borderline personality disorder and anxiety on neuropsychological performance in major depression. J Pers Disord 2006; 20: 55-70.
18. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV: Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 2006; 81: 313-322. (Pubitemid 43152458)
19. First MB, Spitzer RL, Gibbon M, Williams J: Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition: SCID-I/P. Washington, American Psychiatric Press, 1996.
20. Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D, Namia C, Novella L, Petrachi M: Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. J Pers Disord 1997; 11: 279-284. (Pubitemid 27478022)
21. Mangiaracina J, Simon MJ: Comparison of the PPVT-R and WAIS-R in state hospital psychiatric patients. J Clin Psychol 1986; 42: 817-820. (Pubitemid 16026622)
22. Grant DA, Berg EA: A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. J Exp Psychol 1948; 38: 404-411.
23. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, Neuropsychology Press, 1985.
24. Buschke H, Fuld PA: Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974; 24: 1019-1025.
25. Sivan AB: Benton Visual Retention Test, ed 5. San Antonio, Psychological Corporation, 1992.
26. Cornblatt BA, Keilp JG: Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 1994; 20: 31-46. (Pubitemid 24071091)
27. Keilp JG, Sackeim HA, Mann JJ: Correlates of trait impulsiveness in performance measures and neuropsychological tests. Psychiatry Res 2005; 135: 191-201. (Pubitemid 40984611)
28. MacLeod CM: Half a century of research on the Stroop effect: an integrative review. Psychol Bull 1991; 109: 163-203.
29. Baddeley AD: A three minute reasoning test based on grammatical transformations. Psychon Sci 1968; 10: 1019-1025.
30. Cohen JD, Forman SD, Braver TS, Casey BJ, Servan-Schreiber D, Noll DC: Activation of prefrontal cortex in a non-spatial working memory task with functional MRI. Hum Brain Map 1994; 1: 293-304.
31. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
32. Oldham JM, Bender DS, Skodol AE, Dyck IR, Sanislow CA, Yen S, Grilo CM, Shea MT, Zanarini MC, Gunderson EJ, McGlashan TH: Testing an APA practice guideline: symptom-targeted medication utilization for patients with borderline personality disorder. J Psychiatr Pract 2004; 10: 156-161. (Pubitemid 38669723)
33. Barratt ES: Impulsiveness and aggression; in Monahan J, Steadman HJ (eds): Violence and Mental Disorder: Developments in Risk Assessment. Chicago, University of Chicago Press, 1994, pp 61-79.
34. Hilbe JM: Negative binomial regression. Cambridge, Cambridge University Press, 2007.
35. Lenzenweger MF, Clarkin JF, Fertuck EA, Kernberg OF: Executive neurocognitive functioning and neurobehavioral systems indicators in borderline personality disorder: a preliminary study. J Pers Disord 2004; 18: 421-438. (Pubitemid 39518504)
36. Castaneda R, Lifshutz H, Galanter M, Medalia A, Franco H: Treatment compliance after detoxification among highly disadvantaged alcoholics. Am J Drug Alcohol Abuse 1992; 18: 223-234.
37. Harris AH, McKellar JD, Moos RH, Schaefer JA, Cronkite RC: Predictors of engagement in continuing care following residential substance use disorder treatment. Drug Alcohol Depend 2006; 84: 93-101. (Pubitemid 44107640)
38. Penades R, Catalan R, Pujol N, Puig O, Guarch J, Masana G, Navarro V, Gasto C: Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia? Psychother Psychosom 2010; 79: 129-130.
39. Keilp JG, Sackeim HA, Brodsky BS, Oquendo MA, Malone KM, Mann JJ: Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 2001; 158: 735-741. (Pubitemid 32429841)
40. Ogrodniczuk JS: New directions in treatment research for personality disorders: effectiveness of different levels of care. Psychother Psychosom 2011; 80: 65-69.
41. Bartak A, Andrea H, Spreeuwenberg MD, Ziegler UM, Dekker J, Rossum BV, Hamers EFM, Scholte W, Aerts J, Busschbach JJV, Verheul R, Stijnen T, Emmelkamp PMG: Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with cluster B personality disorders. Psychother Psychosom 2011; 80: 28-38.